Sales Growth YoY (Last 12 Months): Arcus Biosciences, Inc. (RCUS)

Public company logo of Arcus Corp (RCUS)

Geopolitical tensions and the decoupling of ties are hindering the global research efforts of Arcus Biosciences, Inc. (RCUS), which is weighing on the stock price. However, the financial foundation relies on a diversified drug portfolio and support from industry behemoths, while human capital is being strengthened by the loyalty of leading immunologists. The TTM annual revenue growth rate visualizes current sales dynamics, where the -58.30 mark serves as a key metric for assessing operational progress.

Arcus Biosciences (RCUS) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

Arcus Biosciences (RCUS) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Arcus Biosciences, Inc.
Product sample of arcusbio.com

Revenue dynamics determine the fairness of an asset's market valuation, preventing overpayment for business stagnation by analyzing cash flow expansion rates. The LTM annual change in sales volume measures demand resilience, reflecting for Arcus Biosciences, Inc. (RCUS) the efficiency of securing milestone payments from pharma behemoths and investments in immunotherapy development, which is critical prior to the stage of extracting royalty profits.

Competitors of Arcus Biosciences, Inc. (RCUS)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Zymeworks Biopharmaceuticals (ZYME) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Tango Pharma (TNGX)|Revenue Growth YoY (Last 12 Months) IOVA|IMTX - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XNCR (Xencor Corp)|Revenue Change YoY (Last 12 Months) CMPX|Sales Growth YoY (TTM) REPL (Replimune)|Revenue Dynamics YoY (Last Twelve Months) LYEL|innate-pharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Pyxis Oncology|Compugen Limited (CGEN) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)